Back
American Shared Hospital Services Vs. Neurocrine Biosciences, Inc. Industry Stock Comparison
Sell
36
AMS
American Shared Hospital Services
Last Price:
$2.11
Seasonality Move:
6.63%
Buy
58
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$140.61
Seasonality Move:
3.52%
Sell
36
American Shared Hospital Services (AMS)
is a Sell
Is American Shared Hospital Services a Buy, Sell or Hold?
-
The current American Shared Hospital Services [AMS] share price is $2.11. The Score for AMS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
AMS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy, Sell or Hold?
-
The current Neurocrine Biosciences, Inc. [NBIX] share price is $140.60. The Score for NBIX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMS Stock Price Chart
What is American Shared Hospital Services's stock price today?
-
The American Shared Hospital Services share price today is $2.11The current trend is relatively stagnant and AMS is experiencing slight buying pressure.
NBIX Stock Price Chart
What is Neurocrine Biosciences, Inc.'s stock price today?
-
The Neurocrine Biosciences, Inc. share price today is $140.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight buying pressure.
AMS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 49.08 | Sell |
| Chaikin Money Flow: | 1082 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.13) | Buy |
| Bollinger Bands (100): | (2.1 - 2.54) | Sell |
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.6 | Sell |
| Relative Strength Index (14 RSI): | 38.23 | Sell |
| Chaikin Money Flow: | 137673 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.96 - 154.22) | Sell |
| Bollinger Bands (100): | (136.69 - 149.11) | Sell |
AMS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Sell |
| 20-day SMA: | 2.1 | Buy |
| 50-day SMA: | 2.14 | Sell |
| 200-day SMA: | 2.46 | Sell |
| 8-day EMA: | 2.11 | Sell |
| 20-day EMA: | 2.11 | Sell |
| 50-day EMA: | 2.17 | Sell |
| 200-day EMA: | 2.44 | Sell |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 144.25 | Sell |
| 20-day SMA: | 148.41 | Sell |
| 50-day SMA: | 146.74 | Sell |
| 200-day SMA: | 131.05 | Buy |
| 8-day EMA: | 143.48 | Sell |
| 20-day EMA: | 145.93 | Sell |
| 50-day EMA: | 145.67 | Sell |
| 200-day EMA: | 136.72 | Buy |
American Shared Hospital Services Earnings Growth & AMS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurocrine Biosciences, Inc. Earnings Growth & NBIX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.26 per share, and an increase next year of $1.51 per share.
American Shared Hospital Services Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurocrine Biosciences, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||